Skip to content
value.today

PierianDx, Inc.

🇺🇸 St. Louis, Missouri, USABiotechnologyFounded 2015
Total raised
$42 M
3 rounds on record
Latest round
$17 M
Jun 2021
First round on record
Jan 2018
Today
Private
No later event on record

Funding rounds

3 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of PierianDx, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jun 2021$17 MNo. 3$10 to $50 million

PierianDx, Inc.: Raise no. 3, Jun 2021

Investors in this round

13 investors had bought by the notice of Nov 9, 2021: 13 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$17 M of $17 M offered
Smallest investment taken
$50,000
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$300,000
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Mark McDonough · Executive Officer, Director
  • Rakesh Nagarajan · Executive Officer, Director
  • Barnard Buscemi · Director
  • Bryan Carey · Director
  • Frederick Hessler · Director
  • Joseph Boorady · Director
  • Kerry Propper · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Cowen and Company, LLC (CRD 7616) · broker-dealer Cowen and Company, LLC (CRD 7616) · New York, New YorkSold in NY

Remarks in the notice

  • On the use of proceeds: “A portion of the gross proceeds will be used for general working capital, which may include salary payments to executive officers and directors. An estimate of such amount is unknown at this time.”

Signed by Patrick Paterson, Attorney-in-fact. Source: SEC Form D, newest notice filed Nov 9, 2021. Read the notice at the SEC.

equity, optionsSEC
Nov 2019$22 MNo. 2$10 to $50 million

PierianDx, Inc.: Raise no. 2, Nov 2019

Investors in this round

13 investors had bought by the notice of Nov 25, 2019: 13 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$22 M of $27 M offered; $5 M still to sell
Smallest investment taken
$50,000
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Chris Callahan · Executive Officer
  • James Starr · Executive Officer
  • Michael Sanderson · Executive Officer, Director
  • Rakesh Nagarajan · Executive Officer, Director
  • Brian Carey · Director
  • Charles Boorady · Director
  • Frederick Hessler · Director
  • Kerry Propper · Director
  • Peter Jobse · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “A portion of the gross proceeds will be used for general working capital, which may include salary payments to executive officers and directors. An estimate of such amount is unknown at this time.”

Signed by Patrick Paterson, Attorney-in-fact. Source: SEC Form D, newest notice filed Nov 25, 2019. Read the notice at the SEC.

equitySEC
Jan 2018$3 MNo. 1$2 to $10 million

PierianDx, Inc.: Raise no. 1, Jan 2018

Investors in this round

4 investors had bought by the notice of Feb 12, 2018: 4 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $5 M offered; $2 M still to sell
Smallest investment taken
$60,000
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Rakesh Nagarajan · Executive Officer, Director
  • Brian Carey · Director
  • Charles Boorady · Director
  • Frederick Hessler · Director
  • Peter Jobse · Director
  • Reid Robison · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “A portion of the gross proceeds will be used for general working capital, which may include salary payments to executive officers and directors. An estimate of such amount is unknown at this time.”

Signed by Patrick Paterson, Attorney-in-fact. Source: SEC Form D, newest notice filed Feb 12, 2018. Read the notice at the SEC.

equity, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • PierianDx, Inc. chose not to state its revenue in its newest notice of a funding round (Nov 2021).

    SEC Form D · Nov 2021

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Nov 2021

That is all the official record says: PierianDx, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of PierianDx, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 13 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by PierianDx, Inc.
NameRoleNamed in
Mark McDonoughExecutive officerNov 2021
Rakesh NagarajanExecutive officerNov 2021
Chris CallahanExecutive officerNov 2019
James StarrExecutive officerNov 2019
Michael SandersonExecutive officerNov 2019
Barnard BuscemiDirectorNov 2021
Bryan CareyDirectorNov 2021
Frederick HesslerDirectorNov 2021
Joseph BooradyDirectorNov 2021
Kerry PropperDirectorNov 2021
Mark McDonoughDirectorNov 2021
Rakesh NagarajanDirectorNov 2021
Brian CareyDirectorNov 2019
Charles BooradyDirectorNov 2019
Michael SandersonDirectorNov 2019
Peter JobseDirectorNov 2019
Reid RobisonDirectorFeb 2018